BioLineRx Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioLineRx Ltd. generated cash of -$22,608,000, which is more than the previous year. Cash used in financing activities reached the amount of $15,056,000 last year. Net change in cash is therefore -$6,332,000.
Cash Flow
| 2014 | -14.47M | -18.16M | 30.25M |
|---|---|---|---|
| 2015 | -14.16M | -15.6M | 29.48M |
| 2016 | -14.51M | 9.29M | 2.09M |
| 2017 | -20.54M | -15.92M | 38.68M |
| 2018 | -24.19M | 9.55M | 13.09M |
| 2019 | -22.66M | 5.25M | 19.19M |
| 2020 | -23.20M | 16.66M | 17.86M |
| 2021 | -23.57M | -38.22M | 57.74M |
| 2022 | -26.24M | 4.00M | 20.43M |
| 2023 | -22.60M | 1.44M | 15.05M |
BLRX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.58M | 12.99M | 16.83M | 5.29M | 3.40M | 5.11M | 2.46M | 5.54M | 5.79M | 7.93M |
Operating activities | ||||||||||
Net income | -60.61M | -24.95M | -27.05M | -30.02M | -25.44M | -22.96M | -24.35M | -15.84M | -14.4M | -10.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.38M | 654K | 703K | 934K | 940K | 545K | 481K | 482K | 441K | 246.53K |
Stock-based compensation expense | 2.32M | 2.24M | 1.49M | 1.27M | 1.75M | 0 | 1.50M | 1.07M | 1.15M | 968.68K |
| Deferred income tax benefit | 2.32M | 2.24M | 1.49M | 1.27M | 1.75M | 0 | 1.50M | 1.07M | 1.15M | 968.68K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.31M | -650K | 24K | 428K | 1.10M | 0 | -414.72K | 0 | -42K | 73.44K |
Inventories | -1.95M | 650K | -24K | -428K | -1.10M | 0 | 0 | 0 | -196K | -302K |
Accounts payable | 5.51M | 1.88M | -564K | -1.71M | 3.21M | -773K | 3.06M | 369K | 196K | 302K |
Cash generated by operating activities | -22.60M | -26.24M | -23.57M | -23.20M | -22.66M | -24.19M | -20.54M | -14.51M | -14.16M | -14.47M |
Investing activities | ||||||||||
Purchases Of Investments | -47.58M | -44M | -78M | -33.5M | -43.54M | -26.5M | -44.01M | -32.98M | -63.13M | -53.01M |
Investments In Property Plant And Equipment | -297K | -316K | -97K | 0 | -73K | -10.21M | -4.23M | -55K | -2.71M | -178.48K |
Acquisitions Net | -1.56M | -4.13K | 38.12K | 0 | 6K | 1.5M | -1M | 3K | -202K | -5.39K |
Cash generated by investing activities | 1.44M | 4.00M | -38.22M | 16.66M | 5.25M | 9.55M | -15.92M | 9.29M | -15.6M | -18.16M |
Financing activities | ||||||||||
Common Stock Issued | 14.08M | 14.35M | 50.40M | 21.21M | 20.29M | 3.83M | 38.77M | 2.18M | 29.05M | 30.25M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.98M | 6.07M | -3.57M | -3.35M | -1.10M | -411K | -93K | -93K | 436K | 0 |
Cash used in financing activities | 15.05M | 20.43M | 57.74M | 17.86M | 19.19M | 13.09M | 38.68M | 2.09M | 29.48M | 30.25M |
Net Change In Cash | -6.33M | -2.40M | -3.84M | 11.53M | 1.89M | -1.70M | 2.64M | -3.07M | -246K | -2.14M |
Cash at end of period | 4.25M | 10.58M | 12.99M | 16.83M | 5.29M | 3.40M | 5.11M | 2.46M | 5.54M | 5.78M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |